Research
& Development
FARMAK excels in developing pharmaceutical products across various therapeutic areas. Our extensive capabilities encompass the creation of new products, along with proficiency in validation, stability assessment, documentation, and transfers.
0
Intricate medicines
in pipeline
0
New launches
every year
0 +
R&D
laboratories
$0M
Aprox. annual R&D investment
R&D complex comprises 12 laboratories and 1 pilot site, featuring specialized units. Currently, we are advancing the development of around 100 complex medications, launching up to 20 new drugs annually.
API synthesis
laboratory
Biotechnological API
synthesis laboratory
Molecular and cellular
biotech laboratory for
personalised medicine
4 diversified analytical
laboratories
5 technological laboratories
for different domains
Bringing innovations
to life
FARMAK’s R&D capabilities covering the entire product development lifecycle. This includes advanced formulation, manufacturing processes, and detailed analytical procedures for a variety of release forms. Our approach combines reliability with innovation, ensuring we deliver trustworthy and effective healthcare solutions.
Simple oral dosage forms
- Immediate release tablets
- Orodispersible and chewable tablets
- Oral solutions
- Suspensions
Complex solid dosage forms
- Extended-Release products
- Multilayer tablets
- Multiparticulate system
- Soft gelatin capsules
Transdermal formulations
- Ointments
- Gels
Simple sterile liquids
- Vials
- Ampoules
- Pre-filled syringes
Complex injectables
- Lyophilized
- Extended-release injectables/Injectable suspensions
- Non-aqueous formulations
- Emulsions
- Validation of manufacturing and analytical procedures/methods,
- Stability testing and execution of official stability batches,
- Documentation generation required for drug product registration.
Seamless project transfers to TechTransfer Centers and Contract Manufacturing Organizations (CMOs)
R&D
Centers
